Life Sciences Manufacturing and Quality: The New Path to Performance
It is no secret that Life Science manufacturers have substantial compliance challenges. Regulatory burdens are getting more intense, regularly changing, and growing in complexity. This is most keenly felt by those that are delivering products in multiple markets.
Successful manufacturers will plot a journey from conformance to performance by merging the objectives, cultures, processes, and technologies between quality and manufacturing.
This new research by LNS explores survey results of over 1200 life science leaders, provides guidance regarding maturity, objectives, and the connection between “IT/OT” and quality, and prescribes a new path for performance. The report also illustrates the correlation between targeted best practices and improved performance.
|Benefits of reading this whitepaper||Challenges Addressed|
Or if you're already a Pharma IQ member, sign in below to download. Sign In Subscribe